148 related articles for article (PubMed ID: 16278379)
21. Lack of prognostic and predictive value of CA IX in radiotherapy of squamous cell carcinoma of the head and neck with known modifiable hypoxia: an evaluation of the DAHANCA 5 study.
Eriksen JG; Overgaard J;
Radiother Oncol; 2007 Jun; 83(3):383-8. PubMed ID: 17543403
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy.
Koukourakis MI; Giatromanolaki A; Sivridis E; Simopoulos K; Pastorek J; Wykoff CC; Gatter KC; Harris AL
Clin Cancer Res; 2001 Nov; 7(11):3399-403. PubMed ID: 11705854
[TBL] [Abstract][Full Text] [Related]
23. Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas.
Le QT; Kong C; Lavori PW; O'byrne K; Erler JT; Huang X; Chen Y; Cao H; Tibshirani R; Denko N; Giaccia AJ; Koong AC
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):167-75. PubMed ID: 17707270
[TBL] [Abstract][Full Text] [Related]
24. Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer.
Generali D; Fox SB; Berruti A; Moore JW; Brizzi MP; Patel N; Allevi G; Bonardi S; Aguggini S; Bersiga A; Campo L; Dogliotti L; Bottini A; Harris AL
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):550-8. PubMed ID: 17255277
[TBL] [Abstract][Full Text] [Related]
25. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.
Kaanders JH; Wijffels KI; Marres HA; Ljungkvist AS; Pop LA; van den Hoogen FJ; de Wilde PC; Bussink J; Raleigh JA; van der Kogel AJ
Cancer Res; 2002 Dec; 62(23):7066-74. PubMed ID: 12460928
[TBL] [Abstract][Full Text] [Related]
26. The prognostic value of immunohistochemical markers for oral tongue squamous cell carcinoma.
Hwa JS; Kwon OJ; Park JJ; Woo SH; Kim JP; Ko GH; Seo JH; Kim RB
Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):2953-9. PubMed ID: 25169079
[TBL] [Abstract][Full Text] [Related]
27. The prognostic value of hypoxia markers in T2-staged oral tongue cancer.
Roh JL; Cho KJ; Kwon GY; Ryu CH; Chang HW; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Jan; 45(1):63-8. PubMed ID: 18620902
[TBL] [Abstract][Full Text] [Related]
28. In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapy.
Secades P; de Santa-María IS; Merlo A; Suarez C; Chiara MD
Head Neck; 2015 Aug; 37(8):1150-62. PubMed ID: 24798801
[TBL] [Abstract][Full Text] [Related]
29. Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX.
Korkolopoulou P; Perdiki M; Thymara I; Boviatsis E; Agrogiannis G; Kotsiakis X; Angelidakis D; Rologis D; Diamantopoulou K; Thomas-Tsagli E; Kaklamanis L; Gatter K; Patsouris E
Hum Pathol; 2007 Apr; 38(4):629-38. PubMed ID: 17367605
[TBL] [Abstract][Full Text] [Related]
30. Increase in gene dosage is a mechanism of HIF-1alpha constitutive expression in head and neck squamous cell carcinomas.
Secades P; Rodrigo JP; Hermsen M; Alvarez C; Suarez C; Chiara MD
Genes Chromosomes Cancer; 2009 May; 48(5):441-54. PubMed ID: 19235921
[TBL] [Abstract][Full Text] [Related]
31. mRNA expression levels of hypoxia-induced and stem cell-associated genes in human glioblastoma.
Bache M; Rot S; Keßler J; Güttler A; Wichmann H; Greither T; Wach S; Taubert H; Söling A; Bilkenroth U; Kappler M; Vordermark D
Oncol Rep; 2015 Jun; 33(6):3155-61. PubMed ID: 25963717
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia, metabolism, and growth factor signaling in head and neck squamous cell carcinoma: correlation between primary and xenograft tumors.
Stegeman H; Rademakers SE; Span PN; Takes RP; van der Kogel AJ; Kaanders JH; Bussink J
Head Neck; 2014 Sep; 36(9):1288-95. PubMed ID: 24668936
[TBL] [Abstract][Full Text] [Related]
33. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.
Jonathan RA; Wijffels KI; Peeters W; de Wilde PC; Marres HA; Merkx MA; Oosterwijk E; van der Kogel AJ; Kaanders JH
Radiother Oncol; 2006 Jun; 79(3):288-97. PubMed ID: 16730088
[TBL] [Abstract][Full Text] [Related]
34. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
Cohen NA; Lai SY; Ziober AF; Ziober BL
Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
[TBL] [Abstract][Full Text] [Related]
35. Hypoxia-inducible factors HIF-1alpha and HIF-2alpha in head and neck cancer: relationship to tumor biology and treatment outcome in surgically resected patients.
Beasley NJ; Leek R; Alam M; Turley H; Cox GJ; Gatter K; Millard P; Fuggle S; Harris AL
Cancer Res; 2002 May; 62(9):2493-7. PubMed ID: 11980639
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor receptor inhibition reduces angiogenesis via hypoxia-inducible factor-1α and Notch1 in head neck squamous cell carcinoma.
Wang WM; Zhao ZL; Ma SR; Yu GT; Liu B; Zhang L; Zhang WF; Kulkarni AB; Sun ZJ; Zhao YF
PLoS One; 2015; 10(2):e0119723. PubMed ID: 25723392
[TBL] [Abstract][Full Text] [Related]
37. Erythropoietin signaling promotes invasiveness of human head and neck squamous cell carcinoma.
Mohyeldin A; Lu H; Dalgard C; Lai SY; Cohen N; Acs G; Verma A
Neoplasia; 2005 May; 7(5):537-43. PubMed ID: 15967106
[TBL] [Abstract][Full Text] [Related]
38. Expression of erythropoietin and erythropoietin receptor in cervical cancer and relationship to survival, hypoxia, and apoptosis.
Leo C; Horn LC; Rauscher C; Hentschel B; Liebmann A; Hildebrandt G; Höckel M
Clin Cancer Res; 2006 Dec; 12(23):6894-900. PubMed ID: 17145806
[TBL] [Abstract][Full Text] [Related]
39. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression.
Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T
Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338
[TBL] [Abstract][Full Text] [Related]
40. Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors.
Sobhanifar S; Aquino-Parsons C; Stanbridge EJ; Olive P
Cancer Res; 2005 Aug; 65(16):7259-66. PubMed ID: 16103077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
